These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Action of apomorphine, bromocriptine and lergotrile on gamma-aminobutyric acid and acetylcholine release in nucleus accumbens and corpus striatum. de Belleroche J; Gardiner IM J Neural Transm; 1983; 58(3-4):153-68. PubMed ID: 6141217 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of bromocriptine-induced cage climbing behaviour in mice by the selective D-2 dopamine receptor antagonists, metoclopramide and molindone. Balsara JJ; Nandal NV; Gada VP; Bapat TR; Chandorkar AG Indian J Physiol Pharmacol; 1986; 30(1):85-90. PubMed ID: 2950056 [TBL] [Abstract][Full Text] [Related]
4. Effect of bromocriptine and ergometrine on striatal acetylcholine content in the rat. Mantovani P; Taddei E; Gorelli B; Santicioli P Agressologie; 1988 Jan; 29(1):19-20. PubMed ID: 3394897 [No Abstract] [Full Text] [Related]
5. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors. Rosenfeld MR; Dvorkin B; Klein PN; Makman MH Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486 [TBL] [Abstract][Full Text] [Related]
6. The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: metoclopramide, thiethylperazine, and molindone as pharmacological tools. Robinson SE; Berney S; Mishra R; Sulser F Psychopharmacology (Berl); 1979 Aug; 64(2):141-7. PubMed ID: 40288 [No Abstract] [Full Text] [Related]
7. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. LaHoste GJ; Marshall JF Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015 [TBL] [Abstract][Full Text] [Related]
8. Enhanced response to the inhibitory action of LY171555, a dopamine D2-agonist, on in vivo striatal dopamine release in DOCA/NaCl-hypertensive rats. Chen YF; Oparil S Brain Res; 1987 Jan; 400(2):225-31. PubMed ID: 2949797 [TBL] [Abstract][Full Text] [Related]
9. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors. Berzétei IP; Bagdy E; Hardy M; Borsy J Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077 [TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites. Wong DT; Threlkeld PG; Bymaster FP Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223 [TBL] [Abstract][Full Text] [Related]
11. Effect of chronic ethanol treatment on dopamine receptor subtypes in rat striatum. Lucchi L; Moresco RM; Govoni S; Trabucchi M Brain Res; 1988 May; 449(1-2):347-51. PubMed ID: 2969275 [TBL] [Abstract][Full Text] [Related]
12. Neurochemical effects of some ergot derivatives: a basis for their antiparkinson actions. Markstein R J Neural Transm; 1981; 51(1-2):39-59. PubMed ID: 6267192 [TBL] [Abstract][Full Text] [Related]
13. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats. Henselmans JM; Hoogland PV; Stoof JC Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666 [TBL] [Abstract][Full Text] [Related]
14. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. Claustre Y; Fage D; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197 [TBL] [Abstract][Full Text] [Related]
15. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. Onali P; Olianas MC; Gessa GL Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769 [TBL] [Abstract][Full Text] [Related]
16. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry. Palij P; Bull DR; Sheehan MJ; Millar J; Stamford J; Kruk ZL; Humphrey PP Brain Res; 1990 Feb; 509(1):172-4. PubMed ID: 2137719 [TBL] [Abstract][Full Text] [Related]
17. Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action. Consolo S; Ladinsky H; Pugnetti P; Fusi R; Crunelli V Life Sci; 1981 Aug; 29(5):457-65. PubMed ID: 7278497 [No Abstract] [Full Text] [Related]
18. Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release. Robertson GS; Hubert GW; Tham CS; Fibiger HC Eur J Pharmacol; 1992 Aug; 219(2):323-5. PubMed ID: 1358643 [TBL] [Abstract][Full Text] [Related]
19. Effect of moxestrol on haloperidol-induced changes in striatal acetylcholine levels and dopamine turn-over. Euvrard C; Labrie F; Boissier JR Commun Psychopharmacol; 1979; 3(5):329-34. PubMed ID: 548211 [No Abstract] [Full Text] [Related]
20. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release. Hoffmann IS; Talmaciu RK; Cubeddu LX J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]